Clinical factors | Gain | Phase | ||||||
---|---|---|---|---|---|---|---|---|
Ipsilateral | Contralateral | Ipsilateral | Contralateral | |||||
OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | 95% CI | |
Model 1 | ||||||||
Age, years | 1.00 | 0.99–1.01 | 1.00 | 0.99–1.01 | 0. 69 | 0.46–1.02 | 0.84 | 0.57–1.25 |
Sex (male) | 1.20 | 0.91–1.58 | 1.16 | 0.92–1.47 | 1. 50 | 0–73,665.66 | 114.17 | 0–5,727,688.9 |
Hypertension | 1.24 | 0.97–1.58 | 1.13 | 0.92–1.40 | 0 | 0–57.60 | 0.01 | 0–187.22 |
Diabetes mellitus | 1.25 | 1.00–1.56 | 1.17 | 0.97–1.41 | 0.63 | 0–3498.39 | 81.05 | 0.01–460,940.38 |
Total CSVD burden score | 0.96 | 0.88–1.05 | 0.98 | 0.91–1.06 | 3.01 | 0.1–89.65 | 1.96 | 0.07–58.79 |
MAP on admission, mmHg | 0.99a | 0.98–1.00 | 0.99a | 0.99–1.00 | 0.93 | 0.7–1.23 | 0.90 | 0.68–1.2 |
Model 2 | ||||||||
Age, years | 1.00 | 1–1.01 | 1.00 | 0.99–1.01 | 0.70 | 0.48–1.02 | 0.88 | 0.60–1.28 |
Sex (male) | 1.25 | 0.94–1.66 | 1.19 | 0.93–1.51 | 1.78 | 0–95,380.3 | 137.52 | 0–7,720,138.07 |
Hypertension | 1.19 | 0.93–1.52 | 1.09 | 0.89–1.34 | 0 | 0–24.58 | 0.01 | 0–58.42 |
Diabetes mellitus | 1.32a | 1.06–1.64 | 1.22a | 1.01–1.47 | 1.00 | 0–4319.18 | 159.08 | 0.04–711,293.88 |
Total CSVD burden score | 0.94 | 0.86–1.02 | 0.96 | 0.90–1.04 | 2.56 | 0.09–72.83 | 1.57 | 0.05–45.22 |
MAP > 105 mmHg on admission | 0.77a | 0.63–0.94 | 0.85 | 0.72–1.01 | 0.31 | 0–643.45 | 0.25 | 0–544.41 |